Structural characterization of melphalan modified 2'-oligodeoxynucleotides by miniaturized LC-ES MS/MS.
In this study a miniaturized LC coupled to electrospray tandem mass spectrometry was used to analyze modifications originating from the interaction between the chemotherapeutic agent melphalan and 2'-oligodeoxynucleotides. Low energy CAD product ion spectra gave information about the specificity of melphalan alkylation with regard to certain DNA sequences. These data can be very useful to estimate the risk in the development of secondary leukaemia as a result of a melphalan cure. In the study of the interaction between melphalan and d(GG), differentiation could be made between alkylation on the 5'-side and alkylation on the 3'-side, because of the presence or absence of the alkylated w1 fragment in the low energy CAD spectra. In the other di-mers alkylation specificity for the different bases could be observed. Melphalan alkylation occurs in the sequence G > A > C > T. The study of the alkylated d(GGGG) revealed the presence of mainly 5'-end alkylation. Furthermore studies were performed which investigated other melphalan treated di-, tetra-, hepta-, and octa-mers.
Van den Driessche
Bart
B
Nucleoside Research and Mass Spectrometry Unit, Department of Chemistry, University of Antwerp, Antwerp, Belgium.
Lemière
Filip
F
van Dongen
Walter
W
Esmans
Eddy L
EL
D000478:Alkylation; D018906:Antineoplastic Agents, Alkylating / Q000737:chemistry*; D001483:Base Sequence; D002845:Chromatography; D008558:Melphalan / Q000737:chemistry*; D015394:Molecular Structure; D008970:Molecular Weight; D009838:Oligodeoxyribonucleotides / Q000737:chemistry* / Q000235:genetics; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*
D018906:Antineoplastic Agents, Alkylating; D009838:Oligodeoxyribonucleotides; D008558:Melphalan